| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 380,449 | 384,732 | 402,479 | 474,026 | | Cost of Revenue | 265,479 | 275,833 | 286,053 | 339,053 | | | Gross Profit | 114,970 | 108,899 | 116,426 | 134,973 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 66,097 | 64,636 | 71,428 | 83,712 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,968 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 52,594 | 44,263 | 44,998 | 51,261 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,677 | (1,118) | 36,525 | 3,316 | | Earnings Before Interest And Taxes | 47,582 | 43,145 | 81,523 | 54,577 | | Interest Expense | 27,312 | 30,860 | 22,483 | 26,761 | | Income Before Tax | 20,270 | 12,285 | 59,040 | 27,816 | | Income Tax Expense | 7,678 | 4,487 | 22,622 | 9,215 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,592 | 7,798 | 36,418 | 18,601 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,592 | 7,798 | 36,418 | 18,601 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,592 | $7,798 | $36,418 | $18,601 |
|
0.83% Nasdaq 
Income Statement
